HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-JUN-16 5GJG TITLE CRYSTAL STRUCTURE OF HUMAN TAK1/TAB1 FUSION PROTEIN IN COMPLEX WITH TITLE 2 LIGAND 4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TAK1 KINASE - TAB1 CHIMERA FUSION PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 31-303,UNP RESIDUES 468-504; COMPND 5 EC: 2.7.11.25; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: FUSION OF MITOGEN-ACTIVATED PROTEIN KINASE KINASE COMPND 8 KINASE 7,TGF-BETA-ACTIVATED KINASE 1 AND MAP3K7-BINDING PROTEIN 1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAP3K7, TAK1, TAB1, MAP3K7IP1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, TAK1-TAB1 KINASE EXPDTA X-RAY DIFFRACTION AUTHOR M.IRIE,M.NAKAMURA,T.A.FUKAMI,T.MATSUURA,K.MORISHIMA REVDAT 3 08-NOV-23 5GJG 1 REMARK REVDAT 2 26-FEB-20 5GJG 1 JRNL REMARK REVDAT 1 16-NOV-16 5GJG 0 JRNL AUTH T.MURAOKA,M.IDE,M.IRIE,K.MORIKAMI,T.MIURA,M.NISHIHARA, JRNL AUTH 2 H.KASHIWAGI JRNL TITL DEVELOPMENT OF A METHOD FOR CONVERTING A TAK1 TYPE I JRNL TITL 2 INHIBITOR INTO A TYPE II OR C-HELIX-OUT INHIBITOR BY JRNL TITL 3 STRUCTURE-BASED DRUG DESIGN (SBDD) JRNL REF CHEM.PHARM.BULL. V. 64 1622 2016 JRNL REFN ISSN 0009-2363 JRNL PMID 27803473 JRNL DOI 10.1248/CPB.C16-00606 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 16721 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 892 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.61 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.68 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1169 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.35 REMARK 3 BIN R VALUE (WORKING SET) : 0.3180 REMARK 3 BIN FREE R VALUE SET COUNT : 71 REMARK 3 BIN FREE R VALUE : 0.3110 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2224 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 59.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.06000 REMARK 3 B22 (A**2) : -1.34000 REMARK 3 B33 (A**2) : 7.40000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.266 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.218 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.173 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.605 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.932 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2337 ; 0.018 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2147 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3187 ; 1.950 ; 1.940 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4935 ; 1.087 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 286 ; 8.286 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 92 ;40.581 ;23.696 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 345 ;15.652 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;16.837 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 341 ; 0.108 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2614 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 531 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1153 ; 5.419 ; 6.061 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1152 ; 5.424 ; 6.058 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1436 ; 8.368 ; 9.059 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5GJG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-JUL-16. REMARK 100 THE DEPOSITION ID IS D_1300000882. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-5A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17613 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.610 REMARK 200 RESOLUTION RANGE LOW (A) : 41.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09400 REMARK 200 FOR THE DATA SET : 18.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.87300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2EVA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.18 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.7M SODIUM POTASSIUM PHOSPHATE, REMARK 280 20%(V/V) GLYCEROL AS CRYOPROTECTANT, PH 7.7, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.01500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.61000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 73.37500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.01500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.61000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 73.37500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.01500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 66.61000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 73.37500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.01500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 66.61000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.37500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 177 REMARK 465 THR A 178 REMARK 465 ALA A 179 REMARK 465 CYS A 180 REMARK 465 ASP A 181 REMARK 465 ILE A 182 REMARK 465 GLN A 183 REMARK 465 THR A 184 REMARK 465 HIS A 185 REMARK 465 MET A 186 REMARK 465 THR A 187 REMARK 465 ASN A 188 REMARK 465 ASN A 189 REMARK 465 LYS A 190 REMARK 465 PRO A 472 REMARK 465 GLY A 473 REMARK 465 GLU A 474 REMARK 465 ASP A 475 REMARK 465 GLU A 497 REMARK 465 GLN A 498 REMARK 465 SER A 499 REMARK 465 VAL A 500 REMARK 465 VAL A 501 REMARK 465 THR A 502 REMARK 465 ALA A 503 REMARK 465 PRO A 504 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 34 CG CD CE NZ REMARK 470 GLU A 37 CG CD OE1 OE2 REMARK 470 ARG A 44 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 54 CG CD CE NZ REMARK 470 ARG A 56 NE CZ NH1 NH2 REMARK 470 LYS A 58 CG CD CE NZ REMARK 470 GLU A 66 CG CD OE1 OE2 REMARK 470 GLU A 68 CG CD OE1 OE2 REMARK 470 GLU A 70 CG CD OE1 OE2 REMARK 470 ARG A 71 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 72 CG CD CE NZ REMARK 470 ARG A 79 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 80 CG CD OE1 NE2 REMARK 470 ARG A 83 NE CZ NH1 NH2 REMARK 470 LYS A 91 CE NZ REMARK 470 LYS A 150 CG CD CE NZ REMARK 470 ARG A 155 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 253 CE NZ REMARK 470 LYS A 257 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 278 CG GLU A 278 CD 0.099 REMARK 500 GLU A 296 CD GLU A 296 OE2 0.067 REMARK 500 GLU A 486 CD GLU A 486 OE1 0.078 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 40 152.43 -38.90 REMARK 500 ALA A 57 25.23 32.36 REMARK 500 ARG A 155 -23.12 66.77 REMARK 500 GLU A 202 -8.55 -53.26 REMARK 500 GLN A 299 -26.27 -172.61 REMARK 500 HIS A 495 -118.92 -110.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6V5 A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5GJD RELATED DB: PDB REMARK 900 RELATED ID: 5GJF RELATED DB: PDB DBREF 5GJG A 31 303 UNP O43318 M3K7_HUMAN 31 303 DBREF 5GJG A 468 504 UNP Q15750 TAB1_HUMAN 468 504 SEQADV 5GJG GLY A 26 UNP O43318 EXPRESSION TAG SEQADV 5GJG PRO A 27 UNP O43318 EXPRESSION TAG SEQADV 5GJG LEU A 28 UNP O43318 EXPRESSION TAG SEQADV 5GJG HIS A 29 UNP O43318 EXPRESSION TAG SEQADV 5GJG MET A 30 UNP O43318 EXPRESSION TAG SEQRES 1 A 315 GLY PRO LEU HIS MET ILE ASP TYR LYS GLU ILE GLU VAL SEQRES 2 A 315 GLU GLU VAL VAL GLY ARG GLY ALA PHE GLY VAL VAL CYS SEQRES 3 A 315 LYS ALA LYS TRP ARG ALA LYS ASP VAL ALA ILE LYS GLN SEQRES 4 A 315 ILE GLU SER GLU SER GLU ARG LYS ALA PHE ILE VAL GLU SEQRES 5 A 315 LEU ARG GLN LEU SER ARG VAL ASN HIS PRO ASN ILE VAL SEQRES 6 A 315 LYS LEU TYR GLY ALA CYS LEU ASN PRO VAL CYS LEU VAL SEQRES 7 A 315 MET GLU TYR ALA GLU GLY GLY SER LEU TYR ASN VAL LEU SEQRES 8 A 315 HIS GLY ALA GLU PRO LEU PRO TYR TYR THR ALA ALA HIS SEQRES 9 A 315 ALA MET SER TRP CYS LEU GLN CYS SER GLN GLY VAL ALA SEQRES 10 A 315 TYR LEU HIS SER MET GLN PRO LYS ALA LEU ILE HIS ARG SEQRES 11 A 315 ASP LEU LYS PRO PRO ASN LEU LEU LEU VAL ALA GLY GLY SEQRES 12 A 315 THR VAL LEU LYS ILE CYS ASP PHE GLY THR ALA CYS ASP SEQRES 13 A 315 ILE GLN THR HIS MET THR ASN ASN LYS GLY SER ALA ALA SEQRES 14 A 315 TRP MET ALA PRO GLU VAL PHE GLU GLY SER ASN TYR SER SEQRES 15 A 315 GLU LYS CYS ASP VAL PHE SER TRP GLY ILE ILE LEU TRP SEQRES 16 A 315 GLU VAL ILE THR ARG ARG LYS PRO PHE ASP GLU ILE GLY SEQRES 17 A 315 GLY PRO ALA PHE ARG ILE MET TRP ALA VAL HIS ASN GLY SEQRES 18 A 315 THR ARG PRO PRO LEU ILE LYS ASN LEU PRO LYS PRO ILE SEQRES 19 A 315 GLU SER LEU MET THR ARG CYS TRP SER LYS ASP PRO SER SEQRES 20 A 315 GLN ARG PRO SER MET GLU GLU ILE VAL LYS ILE MET THR SEQRES 21 A 315 HIS LEU MET ARG TYR PHE PRO GLY ALA ASP GLU PRO LEU SEQRES 22 A 315 GLN TYR PRO CYS GLN HIS SER LEU PRO PRO GLY GLU ASP SEQRES 23 A 315 GLY ARG VAL GLU PRO TYR VAL ASP PHE ALA GLU PHE TYR SEQRES 24 A 315 ARG LEU TRP SER VAL ASP HIS GLY GLU GLN SER VAL VAL SEQRES 25 A 315 THR ALA PRO HET 6V5 A 601 42 HETNAM 6V5 N-(2-ISOPROPOXY-4-(4-METHYLPIPERAZINE-1-CARBONYL) HETNAM 2 6V5 PHENYL)-2-(3-(PHENYLCARBAMOYL)PHENYL)THIAZOLE-4- HETNAM 3 6V5 CARBOXAMIDE FORMUL 2 6V5 C32 H33 N5 O4 S FORMUL 3 HOH *36(H2 O) HELIX 1 AA1 ASP A 32 LYS A 34 5 3 HELIX 2 AA2 SER A 67 GLU A 77 1 11 HELIX 3 AA3 GLU A 77 VAL A 84 1 8 HELIX 4 AA4 SER A 111 GLY A 118 1 8 HELIX 5 AA5 THR A 126 SER A 146 1 21 HELIX 6 AA6 LYS A 158 PRO A 160 5 3 HELIX 7 AA7 SER A 192 MET A 196 5 5 HELIX 8 AA8 ALA A 197 GLU A 202 1 6 HELIX 9 AA9 GLU A 208 ARG A 225 1 18 HELIX 10 AB1 PRO A 235 ASN A 245 1 11 HELIX 11 AB2 PRO A 256 TRP A 267 1 12 HELIX 12 AB3 ASP A 270 ARG A 274 5 5 HELIX 13 AB4 SER A 276 MET A 288 1 13 HELIX 14 AB5 ARG A 289 PHE A 291 5 3 HELIX 15 AB6 PHE A 484 HIS A 495 1 12 SHEET 1 AA1 6 HIS A 29 ILE A 31 0 SHEET 2 AA1 6 LEU A 92 CYS A 96 1 O ALA A 95 N HIS A 29 SHEET 3 AA1 6 CYS A 101 GLU A 105 -1 O VAL A 103 N GLY A 94 SHEET 4 AA1 6 LYS A 58 GLN A 64 -1 N ALA A 61 O MET A 104 SHEET 5 AA1 6 GLY A 48 TRP A 55 -1 N ALA A 53 O VAL A 60 SHEET 6 AA1 6 ILE A 36 GLY A 45 -1 N VAL A 42 O VAL A 50 SHEET 1 AA2 2 LEU A 122 PRO A 123 0 SHEET 2 AA2 2 PRO A 301 CYS A 302 -1 O CYS A 302 N LEU A 122 SHEET 1 AA3 2 LEU A 162 VAL A 165 0 SHEET 2 AA3 2 VAL A 170 ILE A 173 -1 O LYS A 172 N LEU A 163 CISPEP 1 ASN A 98 PRO A 99 0 -11.70 CISPEP 2 GLU A 120 PRO A 121 0 0.06 CISPEP 3 GLN A 148 PRO A 149 0 11.52 SITE 1 AC1 11 VAL A 42 ALA A 61 LYS A 63 GLU A 105 SITE 2 AC1 11 TYR A 106 ALA A 107 GLU A 108 GLY A 110 SITE 3 AC1 11 LEU A 163 ASP A 175 PHE A 176 CRYST1 58.030 133.220 146.750 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017232 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007506 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006814 0.00000